celecoxib has been researched along with Lipidoses in 1 studies
Lipidoses: Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norris, PC | 1 |
| Gosselin, D | 1 |
| Reichart, D | 1 |
| Glass, CK | 1 |
| Dennis, EA | 1 |
1 other study available for celecoxib and Lipidoses
| Article | Year |
|---|---|
Phospholipase A2 regulates eicosanoid class switching during inflammasome activation.
Topics: Animals; Aspirin; Celecoxib; Cell Line, Transformed; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inh | 2014 |